United States · FDA National Drug Code directory
Oxybutynin Chloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70954-005_db0e9137-4243-4f35-87fb-19668c1bd480
- Product NDC
- 70954-005
- Form
- TABLET
- Composition / generic term
- Oxybutynin Chloride
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171115
- Source listing expiry
- 20261231
Source-listed ingredients
- OXYBUTYNIN CHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (70954-005-10) · 70954-005-10
- 500 TABLET in 1 BOTTLE (70954-005-20) · 70954-005-20
- 1000 TABLET in 1 BOTTLE (70954-005-30) · 70954-005-30
- 100 BLISTER PACK in 1 CARTON (70954-005-50) / 1 TABLET in 1 BLISTER PACK (70954-005-40) · 70954-005-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →